Effect of verapamil on secondary cardioversion in patients with early atrial fibrillation recurrence after electrical cardioversion.
De Simone
Antonio
A
Laboratorio di Elettrofisiologia, Casa di Cura San Michele, Maddaloni, Italy.
Turco
Pietro
P
De Matteis
Carmine
C
La Rocca
Vincenzo
V
Nocerino
Pasquale
P
Greco
Luciano
L
Astarita
Costantino
C
Messina
Vincenzo
V
Rotunno
Raffaele
R
Iaconelli
Gianfranco
G
Stabile
Eugenio
E
Stabile
Giuseppe
G
D000284:Administration, Oral; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D004554:Electric Countershock; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care; D011446:Prospective Studies; D012086:Reoperation; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome; D014700:Verapamil / Q000008:administration & dosage*
D000889:Anti-Arrhythmia Agents; D014700:Verapamil